Unknown

Dataset Information

0

Structural basis for specific ligation of the peroxisome proliferator-activated receptor ?.


ABSTRACT: The peroxisome proliferator-activated receptor (PPAR) family comprises three subtypes: PPAR?, PPAR?, and PPAR?. PPAR? transcriptionally modulates lipid metabolism and the control of energy homeostasis; therefore, PPAR? agonists are promising agents for treating a variety of metabolic disorders. In the present study, we develop a panel of rationally designed PPAR? agonists. The modular motif affords efficient syntheses using building blocks optimized for interactions with subtype-specific residues in the PPAR? ligand-binding domain (LBD). A combination of atomic-resolution protein X-ray crystallographic structures, ligand-dependent LBD stabilization assays, and cell-based transactivation measurements delineate structure-activity relationships (SARs) for PPAR?-selective targeting and structural modulation. We identify key ligand-induced conformational transitions of a conserved tryptophan side chain in the LBD that trigger reorganization of the H2'-H3 surface segment of PPAR?. The subtype-specific conservation of H2'-H3 sequences suggests that this architectural remodeling constitutes a previously unrecognized conformational switch accompanying ligand-dependent PPAR? transcriptional regulation.

SUBMITTER: Wu CC 

PROVIDER: S-EPMC5380080 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ.

Wu Chyuan-Chuan CC   Baiga Thomas J TJ   Downes Michael M   La Clair James J JJ   Atkins Annette R AR   Richard Stephane B SB   Fan Weiwei W   Stockley-Noel Theresa A TA   Bowman Marianne E ME   Noel Joseph P JP   Evans Ronald M RM  

Proceedings of the National Academy of Sciences of the United States of America 20170320 13


The peroxisome proliferator-activated receptor (PPAR) family comprises three subtypes: PPARα, PPARγ, and PPARδ. PPARδ transcriptionally modulates lipid metabolism and the control of energy homeostasis; therefore, PPARδ agonists are promising agents for treating a variety of metabolic disorders. In the present study, we develop a panel of rationally designed PPARδ agonists. The modular motif affords efficient syntheses using building blocks optimized for interactions with subtype-specific residue  ...[more]

Similar Datasets

| S-EPMC3173080 | biostudies-literature
| S-EPMC4024916 | biostudies-literature
2012-04-19 | GSE32121 | GEO
| S-EPMC2684551 | biostudies-literature